Korro Bio, Inc. - Common Stock (KRRO)
38.63
+2.69 (7.48%)
Korro Bio, Inc. is a biotechnology company focused on advancing RNA-targeted therapies to treat various genetic diseases
The company develops innovative solutions leveraging its proprietary technologies aimed at delivering precise and effective treatments through the modulation of RNA. Korro Bio is dedicated to addressing unmet medical needs by harnessing the potential of RNA biology and transforming therapeutic approaches for patients suffering from serious health conditions. Through its research and development efforts, the company strives to pioneer advances in the field of precision medicine.
Frequently Asked Questions
Is Korro Bio, Inc. - Common Stock publicly traded?
Yes, Korro Bio, Inc. - Common Stock is publicly traded.
What exchange does Korro Bio, Inc. - Common Stock trade on?
Korro Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Korro Bio, Inc. - Common Stock?
The ticker symbol for Korro Bio, Inc. - Common Stock is KRRO on the Nasdaq Stock Market
What is the current price of Korro Bio, Inc. - Common Stock?
The current price of Korro Bio, Inc. - Common Stock is 38.63
When was Korro Bio, Inc. - Common Stock last traded?
The last trade of Korro Bio, Inc. - Common Stock was at 3:14 pm EST on February 5th, 2025